Rapamycin-induced remission of Kaposi's sarcoma is not associated with expansion of cytotoxic T-lymphocyte subsets.

Walsh, Stephen B; Summers, Shaun A; Amlot, Peter L; Sheaff, Michael T; Neild, Guy H

Walsh, Stephen B; Summers, Shaun A; Amlot, Peter L; Sheaff, Michael T; Neild, Guy H.

Afiliación

Walsh SB; UCL Department of Physiology and Centre for Nephrology , Royal Free and University College Medical School , Rowland Hill Street, London , UK.
Summers SA; Department of Medicine, Centre for Inflammatory Disease , Monash University , Melbourne, Victoria , Australia.
Amlot PL; Department of Immunology , Royal Free and University College Medical School , Rowland Hill Street.
Sheaff MT; Department of Histopathology, Bart's and the London National Health Service Trust , Royal London Hospital , Whitechapel, London , UK.
Neild GH; UCL Department of Physiology and Centre for Nephrology , Royal Free and University College Medical School , Rowland Hill Street, London , UK.

NDT Plus ; 1(5): 313-5, 2008 Oct.

Article en En | MEDLINE | ID: mdl-25983921

Palabras clave

Kaposi's sarcoma; VEGF; cytotoxic T-cells; rapamycin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: NDT Plus Año: 2008 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google